Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| SPHL | Springview | $7.64 | -$9.77 | -56.12% | 3.8M | $203M | $1.92$62.40 |
| ANPA | Hong Kong Prosperous Sheep | $102.10 | -$55.79 | -35.34% | 115.9K | $2.0B | $2.80$180.64 |
| MLEC | Moolec Science | $5.12 | -$2.58 | -33.47% | 561.4K | $5.6M | $3.08$157.05 |
| RAYA | Erayak Power Solution Group | $2.70 | -$1.23 | -31.30% | 499.5K | $3.5M | $2.66$737.00 |
| SMCZ | Tidal Trust II - Defiance Daily Target 2x Short Smci ETF | $42.31 | -$12.86 | -23.32% | 595.3K | - | $19.85$225.57 |
| PAVM | PAVmed | $6.75 | -$2.00 | -22.85% | 96.9K | $9.3M | $6.00$26.85 |
| MFI | mF International | $14.03 | -$2.97 | -17.47% | 25.9K | $28M | $4.08$60.73 |
| MTEX | Mannatech | $7.60 | -$1.53 | -16.78% | 55.9K | $17M | $6.90$16.49 |
| AHMA | Ambitions Enterprise Management L.l.c | $24.68 | -$4.70 | -16.00% | 412.1K | $867M | $4.00$31.07 |
| SGML | Sigma Lithium | $11.98 | -$2.27 | -15.93% | 11.7M | $1.6B | $4.25$16.87 |
Related Articles
Featured Article
1 Small-Cap Stock I'd Buy Before GLBE in 2026
Marc Guberti|Jan 8, 2026
Global-E Online is a small company trying to carve out a niche in the competitive e-commerce space, while AXT is a small semiconductor player that already has a lead in an emerging opportunity.
3 Top Stocks Worth Buying for the Long Term in 2023
Michael Byrne|Dec 30, 2022
Opportunities abound as investors close the book on 2022 and turn to 2023.
This Former SPAC Beat the Market in 2022. Is It a Buy for 2023?
Michael Byrne|Dec 23, 2022
This 112-year-old company is growing like it's the next hot start-up.
Advertisement
What's the Outlook for Arbutus Biopharma?
Keith Speights and Brian Orelli, PhD|Feb 5, 2022
The company could have great prospects if its hepatitis B virus therapy is successful in clinical testing.
3 Healthcare Stocks That Rocketed Higher in July
Cory Renauer|Aug 3, 2020
Here's what drove shares of these healthcare stocks through the roof last month.
Tiny Arbutus Biopharma Wins Patent Litigation Fight with COVID-19 Vaccine Implications
Taylor Carmichael|Jul 24, 2020
The ruling means Moderna may have to pay royalties on its mRNA-based vaccines -- including its coronavirus candidate.
